A 2-year longitudinal PBMC gene expression profiling of MS patients receiving interferon-beta 1b predicts therapy outcome

Details

Language :

English

ISSN :

03024350 and 14389428

Issue :

Preprints

Database :

Supplemental Index

Journal :

Aktuelle Neurologie

Publication Type :

Periodical

Accession number :

ejs43585519

Full Text :

https://doi.org/10.1055/s-2007-987763